Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William S Azar

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Scientific Reports|September 30, 2025
Assessment of the validity of ChatGPT-3.5 responses to patient-generated queries following BPH surgeryJad Najdi, Bilal Alameddine, Alexandre Armache, et al.
Antioxidants & Redox Signaling|September 21, 2021
Translational Aspects of the Mammalian Target of Rapamycin Complexes in Diabetic NephropathyAlaa Abou Daher, Sahar Alkhansa, William S Azar, et al.
Journal of Molecular Endocrinology|October 13, 2020
NETosis contributes to the pathogenesis of diabetes and its complicationsRachel Njeim, William S Azar, Angie H Fares, et al.
Urology Practice|December 28, 2023
A Cost Savings Analysis of Topical Estrogen Therapy in Urinary Tract Infection Prevention Among Postmenopausal WomenCharlotte Goldman Houston, William S Azar, Sean Shenghsiu Huang, et al.
Urology Practice|January 12, 2024
Reply by AuthorsCharlotte Goldman Houston, William S Azar, Sean Shenghsiu Huang, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 6, 2026
Optimizing ChatGPT: Applying prompt engineering to frequently asked questions in urologic oncologyMark N Alshak, Michelle I Higgins, Craig Cronin, et al.
Reviews in Endocrine & Metabolic Disorders|August 4, 2020
COVID-19 and diabetes mellitus: how one pandemic worsens the otherWilliam S Azar, Rachel Njeim, Angie H Fares, et al.
Pharmaceutics|March 29, 2023
SGLT2 Inhibitor-Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling MechanismBatoul Dia, Sahar Alkhansa, Rachel Njeim, et al.
Journal of Advanced Research|February 1, 2023
Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney diseasePamela Houeiss, Rachel Njeim, Hani Tamim, et al.
Diabetes|January 20, 2023
VEGF-A: A Novel Mechanistic Link Between CYP2C-Derived EETs and Nox4 in Diabetic Kidney DiseaseRachel Njeim, Kawthar Braych, Hilda E Ghadieh, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Scientific Reports|September 30, 2025
Assessment of the validity of ChatGPT-3.5 responses to patient-generated queries following BPH surgeryJad Najdi, Bilal Alameddine, Alexandre Armache, et al.
Antioxidants & Redox Signaling|September 21, 2021
Translational Aspects of the Mammalian Target of Rapamycin Complexes in Diabetic NephropathyAlaa Abou Daher, Sahar Alkhansa, William S Azar, et al.
Journal of Molecular Endocrinology|October 13, 2020
NETosis contributes to the pathogenesis of diabetes and its complicationsRachel Njeim, William S Azar, Angie H Fares, et al.
Urology Practice|December 28, 2023
A Cost Savings Analysis of Topical Estrogen Therapy in Urinary Tract Infection Prevention Among Postmenopausal WomenCharlotte Goldman Houston, William S Azar, Sean Shenghsiu Huang, et al.
Urology Practice|January 12, 2024
Reply by AuthorsCharlotte Goldman Houston, William S Azar, Sean Shenghsiu Huang, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 6, 2026
Optimizing ChatGPT: Applying prompt engineering to frequently asked questions in urologic oncologyMark N Alshak, Michelle I Higgins, Craig Cronin, et al.
Reviews in Endocrine & Metabolic Disorders|August 4, 2020
COVID-19 and diabetes mellitus: how one pandemic worsens the otherWilliam S Azar, Rachel Njeim, Angie H Fares, et al.
Pharmaceutics|March 29, 2023
SGLT2 Inhibitor-Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling MechanismBatoul Dia, Sahar Alkhansa, Rachel Njeim, et al.
Journal of Advanced Research|February 1, 2023
Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney diseasePamela Houeiss, Rachel Njeim, Hani Tamim, et al.
Diabetes|January 20, 2023
VEGF-A: A Novel Mechanistic Link Between CYP2C-Derived EETs and Nox4 in Diabetic Kidney DiseaseRachel Njeim, Kawthar Braych, Hilda E Ghadieh, et al.
Pageof 2